Multidrug-resistant acinetobacter infection and their susceptibility patterns in a tertiary care hospital
1Department of Microbiology, Institute of Post-Graduate Medical Education and Research, Malda Medical College and Hospital, Kolkata, West Bengal, India.
Background:
Antibiotic-resistant Acinetobacter nosocomial infection is a leading problem. It acts as an opportunistic pathogen to cause a wide spectrum of infection including nosocomial pneumonia, meningitis, endocarditis, skin and soft tissue infections, urinary tract infection, conjunctivitis, burn wound infection and bacteremia. Multidrug-resistant Acinetobacter infection creates a great problem in hospital setting.
Materials And Methods:
The clinical specimens obtained from ICU and different surgical and medical wards were investigated using standard microbiological techniques to know the distribution of and their resistant profile. Antimicrobial resistance was studied using the modified Kirby Bauer disk diffusion technique following the CLSI protocol.
Results:
Major infections found in different medical wards, surgical wards and ICU were due to Acinetobacter baumannii (74.02%), A. lowfii (14.2%), A. haemolyticus (7.79%), A. junii (3.8%) among Acinetobacter spices. Acinetobacter showed increased resistant against majority of commercially available drugs imipenem (5.2%), meropenem (9.75%), piperacillin-tazobactum (18.2%), netilmicin (16.24%), amikacin (14.29%), ceftazidime (74.1%), gentamicin (70.13%), ofloxacin (42.21%).
Conclusion:
A. baumannii was found to be associated with UTI, RTI, septicemia, bacteremia, and meningitis and wound infection. A. baumannii displayed higher resistance to more number of antibiotics than other nosocomial pathogens from ICU.
Insights
Antibiotic-resistant Acinetobacter infections, particularly Acinetobacter baumannii, are a significant hospital concern. This study highlights Acinetobacter baumannii
Area of Science:
- Medical Microbiology
- Infectious Diseases
- Antimicrobial Resistance
Background:
- Antibiotic-resistant Acinetobacter infections pose a major challenge in healthcare settings.
- Acinetobacter species are opportunistic pathogens causing diverse infections like pneumonia, meningitis, and bacteremia.
- Multidrug-resistant Acinetobacter infections present significant difficulties in hospitals.
Purpose of the Study:
- To investigate the distribution and antimicrobial resistance profiles of Acinetobacter species in clinical specimens.
- To identify the predominant Acinetobacter species causing nosocomial infections.
- To assess the resistance patterns of Acinetobacter against commonly used antibiotics.
Main Methods:
- Standard microbiological techniques were employed to analyze clinical specimens from various hospital wards and ICUs.
- Antimicrobial susceptibility testing was performed using the modified Kirby Bauer disk diffusion method.
- The Clinical and Laboratory Standards Institute (CLSI) protocol was followed for resistance testing.
Main Results:
- Acinetobacter baumannii was the most prevalent species (74.02%), followed by A. lowfii (14.2%), A. haemolyticus (7.79%), and A. junii (3.8%).
- High resistance rates were observed against ceftazidime (74.1%), gentamicin (70.13%), and ofloxacin (42.21%).
- Lower resistance was noted for imipenem (5.2%), meropenem (9.75%), and piperacillin-tazobactum (18.2%).
Conclusions:
- Acinetobacter baumannii is frequently associated with urinary tract infections, respiratory tract infections, septicemia, bacteremia, meningitis, and wound infections.
- Acinetobacter baumannii exhibited greater resistance to multiple antibiotics compared to other nosocomial pathogens in the ICU.
- The findings underscore the urgent need for effective antimicrobial stewardship and infection control strategies against multidrug-resistant Acinetobacter.
Related Concept Videos
Mechanism of Antibiotic Resistance in MRSA
Acute Pyelonephritis II: Diagnostic Studies and Management
Clinical Significance of Antibiotic Resistance
Development of Antibiotic Resistance
